Patents by Inventor Marcelo Ariel German

Marcelo Ariel German has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of transgene expression in plants
    Patent number: 11879129
    Abstract: This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in seed tissues of a dicot plant.
    Type: Grant
    Filed: September 12, 2022
    Date of Patent: January 23, 2024
    Inventors: Andrew J. Bowling, Marcelo Ariel German, Todd P. Glancy, Sandeep Kumar, Heather Pence, Andrew E. Robinson, Shreedharan Sriram, Po-Hao Wang, Carla N. Yerkes
  • MODULATION OF TRANSGENE EXPRESSION IN PLANTS
    Publication number: 20230136893
    Abstract: This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in seed tissues of a dicot plant.
    Type: Application
    Filed: September 12, 2022
    Publication date: May 4, 2023
    Applicant: CORTEVA AGRISCIENCE LLC
    Inventors: ANDREW J. BOWLING, MARCELO ARIEL GERMAN, TODD P. GLANCY, SANDEEP KUMAR, HEATHER PENCE, ANDREW E. ROBINSON, SHREEDHARAN SRIRAM, PO-HAO WANG, CARLA N. YERKES
  • Modulation of transgene expression in plants
    Patent number: 11473095
    Abstract: This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in seed tissues of a dicot plant.
    Type: Grant
    Filed: April 23, 2020
    Date of Patent: October 18, 2022
    Assignee: CORTEVA AGRISCIENCE LLC
    Inventors: Sandeep Kumar, Marcelo Ariel German, Po-Hao Wang, Todd P. Glancy, Shreedharan Sriram, Carla N. Yerkes, Andrew J. Bowling, Heather Pence, Andrew E. Robinson
  • TISSUE-SPECIFIC EXPRESSION AND HYBRID PLANT PRODUCTION
    Publication number: 20210171968
    Abstract: This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in male plant tissues, for example, to provide an economical male sterility system of hybrid seed production.
    Type: Application
    Filed: February 3, 2021
    Publication date: June 10, 2021
    Applicant: Dow AgroSciences LLC
    Inventors: Sandeep Kumar, Marcelo Ariel German, Tristan E Coram, Terry R. Wright
  • Tissue-specific expression and hybrid plant production
    Patent number: 10913953
    Abstract: This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in male plant tissues, for example, to provide an economical male sterility system of hybrid seed production.
    Type: Grant
    Filed: July 26, 2018
    Date of Patent: February 9, 2021
    Assignee: Dow AgroSciences LLC
    Inventors: Sandeep Kumar, Marcelo Ariel German, Tristan Coram, Terry R. Wright
  • MODULATION OF TRANSGENE EXPRESSION IN PLANTS
    Publication number: 20200248197
    Abstract: This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in seed tissues of a dicot plant.
    Type: Application
    Filed: April 23, 2020
    Publication date: August 6, 2020
    Applicant: Dow AgroSciences LLC
    Inventors: Sandeep Kumar, Marcelo Ariel German, Pahao Wang, Todd P. Glancy, Shreedharan Sriram, Carla N. Yerkes, Andrew J. Bowling, Heather Pence, Andrew E. Robinson
  • Tissue-specific expression and hybrid plant production
    Patent number: 10683513
    Abstract: This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in male plant tissues, for example, to provide an economical male sterility system of hybrid seed production.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: June 16, 2020
    Assignee: Dow AgroSciences LLC
    Inventors: Sandeep Kumar, Marcelo Ariel German, Tristan Coram, Terry R. Wright
  • TISSUE-SPECIFIC EXPRESSION AND HYBRID PLANT PRODUCTION
    Publication number: 20180346916
    Abstract: This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in male plant tissues, for example, to provide an economical male sterility system of hybrid seed production.
    Type: Application
    Filed: July 26, 2018
    Publication date: December 6, 2018
    Inventors: Sandeep Kumar, Marcelo Ariel German, Tristan Coram, Terry R. Wright
  • Modulation of Transgene Expression in Plants
    Publication number: 20180100162
    Abstract: This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in seed tissues of a dicot plant.
    Type: Application
    Filed: September 15, 2017
    Publication date: April 12, 2018
    Applicant: Dow AgroSciences LLC
    Inventors: Sandeep Kumar, Marcelo Ariel German, Pohao Wang, Todd P. Glancy, Shreedharan Sriram, Carla N. Yerkes, Andrew J. Bowling, Heather Pence, Andrew E. Robinson
  • Use of fructokinases and sucrose synthases for increasing cell wall polymers
    Patent number: 9556421
    Abstract: The invention relates to transgenic plants exhibiting increased cell wall content. In one embodiment, transgenic plants engineered to over-express fructokinase (FRK) or both FRK and sucrose synthase (SuSy) are provided. The FRK+SuSy double-transgenic plants of the invention consistently exhibit enhanced cell wall polymer deposition.
    Type: Grant
    Filed: November 15, 2012
    Date of Patent: January 31, 2017
    Assignee: THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI CENTER)
    Inventors: David Granot, Marcelo Ariel German, Rakefet David-Schwartz, Nir Dai, Arthur Schaffer, Marina Petrikov
  • USE OF FRUCTOKINASES AND SUCROSE SYNTHASES FOR INCREASING CELL WALL POLYMERS
    Publication number: 20150322450
    Abstract: The invention relates to transgenic plants exhibiting increased cell wall content. In one embodiment, transgenic plants engineered to over-express fructokinase (FRK) or both FRK and sucrose synthase (SuSy) are provided. The FRK+SuSy double-transgenic plants of the invention consistently exhibit enhanced cell wall polymer deposition.
    Type: Application
    Filed: November 15, 2012
    Publication date: November 12, 2015
    Inventors: David Granot, Marcelo Ariel German, Rakefet David-Schwartz, Nir Dai, Arthur Schaffer, Marina Petrikov
  • TISSUE-SPECIFIC EXPRESSION AND HYBRID PLANT PRODUCTION
    Publication number: 20150184178
    Abstract: This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in male plant tissues, for example, to provide an economical male sterility system of hybrid seed production.
    Type: Application
    Filed: December 19, 2014
    Publication date: July 2, 2015
    Inventors: Sandeep Kumar, Marcelo Ariel German, Tristan Coram, Terry R. Wright